Sanctuary Advisors LLC Makes New Investment in Sotera Health (NASDAQ:SHC)

Sanctuary Advisors LLC acquired a new stake in Sotera Health (NASDAQ:SHC) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 11,436 shares of the company’s stock, valued at approximately $130,000.

A number of other institutional investors also recently modified their holdings of SHC. CWM LLC grew its stake in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after acquiring an additional 993 shares during the period. Point72 DIFC Ltd increased its stake in Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Sotera Health by 728.0% during the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after buying an additional 8,248 shares during the last quarter. Sandia Investment Management LP bought a new position in shares of Sotera Health in the first quarter valued at $120,000. Finally, Edgestream Partners L.P. acquired a new position in shares of Sotera Health during the second quarter valued at about $125,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Upgrades and Downgrades

SHC has been the topic of a number of analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th. Barclays raised their target price on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 55.12% of the company’s stock.

Sotera Health Trading Down 2.4 %

NASDAQ:SHC opened at $15.62 on Tuesday. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The firm has a 50-day moving average price of $15.83 and a two-hundred day moving average price of $13.33. The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93. The firm has a market cap of $4.42 billion, a price-to-earnings ratio of 111.57 and a beta of 2.07.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The business had revenue of $277.00 million during the quarter, compared to the consensus estimate of $266.45 million. During the same quarter last year, the company posted $0.19 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, equities analysts expect that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.